Science Advances
IDE-mediated GLP-1 degradation as the basis for designing long-acting and CNS-stable GLP-1 receptor agonists
Experiments in animalsInterventions
The paper
Chinese Academy of Sciences
Science Advances, 26 Aug 2026
Related
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Research Square8 Oct 2026
Semaglutide improved heart artery function in pigs
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
